688580 伟思医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.8278.6376.12912.10017.360
总资产报酬率 ROA (%)4.3657.8085.64711.18614.775
投入资产回报率 ROIC (%)4.7328.4445.98411.71610.019

边际利润分析
销售毛利率 (%)71.08371.76472.47874.78173.634
营业利润率 (%)28.91432.11532.47845.27043.572
息税前利润/营业总收入 (%)26.15528.56427.03142.04442.318
净利润/营业总收入 (%)26.79129.47929.17341.28337.829

收益指标分析
经营活动净收益/利润总额(%)70.94076.78370.47077.58184.187
价值变动净收益/利润总额(%)9.7536.41015.12710.4148.084
营业外收支净额/利润总额(%)0.1361.0461.3071.3690.734

偿债能力分析
流动比率 (X)8.6058.27310.20713.81011.027
速动比率 (X)8.3128.0109.93813.51610.738
资产负债率 (%)9.1919.9269.2436.4498.404
带息债务/全部投入资本 (%)0.0730.3060.8342.099--
股东权益/带息债务 (%)134,273.07532,005.58211,681.9854,659.0292,313.762
股东权益/负债合计 (%)987.966907.439981.9201,450.6671,086.116
利息保障倍数 (X)-9.345-7.343-4.599-10.909-26.850

营运能力分析
应收账款周转天数 (天)34.11422.48125.41815.5730.000
存货周转天数 (天)125.780103.095132.738112.1100.000